Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
Leah Andrews, M. Elizabeth Halloran, Lars van der Laan, Yunda Huang et autres
6 citationsJAMA Network Open
Kim Offergeld
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
5Publications signalées
2761Citations signalées
0Affiliations récentes
Domaines associés
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyViral Infections and Outbreaks ResearchCOVID-19 Clinical Research StudiesVirus-based gene therapy research
Publications récentes
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
E Choi, Boris Lacarra, Muhammed O. Afolabi, Boni Maxime Ale et autres
18 citationsThe Lancet Global Health
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
Muhammed O. Afolabi, David Ishola, Daniela Manno, Babajide Keshinro et autres
98 citationsThe Lancet Infectious Diseases
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas et autres
2621 citationsNew England Journal of Medicine
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
Moses Badio, Édouard Lhomme, Mark Kieh, Abdoul Habib Béavogui et autres
18 citationsTrials
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.